Literature DB >> 1483489

Penetration of tinidazole into skin blister fluid following its oral administration.

A Klimowicz1, A Nowak, S Bielecka-Grzela.   

Abstract

Plasma and skin blister fluid concentrations of tinidazole following a single oral dose of 2 g drug, and after multiple doses of 0.25 g every 12 h, were determined. Skin blisters were produced by direct application of 0.25% cantharidin ointment to the skin. The maximum concentration in plasma of about 36 mg.l-1 was observed after about 2 h, whereas in skin blister fluid the peak occurred after about 6 h and was 30 mg.l-1. The half-life in plasma was slightly shorter than in blister fluid at 17 and 19 h, respectively, but the difference was not significant. The penetration of tinidazole into cantharidin-induced skin blister fluid, defined according to Wise as the ratio of the AUCs in blister fluid and plasma was 1.00. During routine treatment with tinidazole (0.25 g every 12 h), the concentrations in plasma and blister fluid collected before and 3 h after the morning dose exceeded the minimal inhibitory concentrations for susceptible pathogens. The results provide a pharmacokinetic basis for the proven efficacy of tinidazole in the treatment of protozoal and anaerobic infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483489     DOI: 10.1007/bf02285095

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.

Authors:  A M Jokipii; L Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

2.  Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route.

Authors:  J Mattila; P T Männistö; R Mäntylä; S Nykänen; U Lamminsivu
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

3.  Concentrations of metronidazole and tinidazole in male genital tissues.

Authors:  J Viitanen; H Haataja; P T Männistö
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

4.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.

Authors:  R Wise; A P Gillett; B Cadge; S R Durham; S Baker
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

5.  The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne.

Authors:  H Akamatsu; M Oguchi; S Nishijima; Y Asada; M Takahashi; T Ushijima; Y Niwa
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

6.  Comparative pharmacokinetics of metronidazole and tinidazole and their tissue penetration.

Authors:  T Bergan; J H Solhaug; O Søreide; O Leinebø
Journal:  Scand J Gastroenterol       Date:  1985-10       Impact factor: 2.423

7.  Plasma and skin blister fluid concentrations of trimethoprim following its oral administration.

Authors:  A Klimowicz; A Nowak; M Kadyków
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 8.  Tinidazole--microbiology, pharmacology and efficacy in anaerobic infections.

Authors:  C E Nord; L Kager
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

9.  Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system.

Authors:  A M Jokipii; L Jokipii
Journal:  Scand J Infect Dis Suppl       Date:  1981

10.  Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.

Authors:  R Wise; I A Donovan; C A McNulty; R Waldron; J M Andrews
Journal:  J Hosp Infect       Date:  1986-03       Impact factor: 3.926

View more
  2 in total

Review 1.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 2.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.